2107 — Chicago, Illinois

2107 is a clinical research site located in Chicago, Illinois, United States.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

2107 has participated in 1 clinical trials.

Therapeutic areas: Advanced Idiopathic Parkinson's Disease.

Sponsors: UCB BIOSCIENCES GmbH.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 2107?

2107 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 2107 conducted?

2107 has 1 clinical trials on record. Their work covers Advanced Idiopathic Parkinson's Disease.

Is 2107 accredited by Crixeo Health?

2107 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 2107?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.